Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
07/2003
07/31/2003WO2003062430A1 Fermentation of pentose sugars
07/31/2003WO2003062429A1 Novel serine protease
07/31/2003WO2003062428A1 Genetic sequences having methyltransferase activity and uses therefor
07/31/2003WO2003062427A1 Method of screening drug for improving insulin resistance
07/31/2003WO2003062426A1 Novel protein, its dna and use thereof
07/31/2003WO2003062425A1 Short fragment homologous recombination to effect targeted genetic alterations in plants
07/31/2003WO2003062424A1 Nucleic acid sequence comprising the rna packaging signal of a group 1 coronavirus and the applications thereof
07/31/2003WO2003062423A2 Method for inhibiting the expression of a target gene resulting from a chromosome aberration
07/31/2003WO2003062422A1 Signalling aptamer complexes
07/31/2003WO2003062421A1 Bispecific antisense olignucleotides that inhibit igfbp-2 and igfbp-5 and methods of using same
07/31/2003WO2003062420A1 Molecular libraries
07/31/2003WO2003062419A1 Methods for multiple parameter screening and evolution of cells to produce small molecules with multiple functionalities
07/31/2003WO2003062418A1 Method and apparatus for detecting nucleic acid data
07/31/2003WO2003062417A1 Rna-dna ligation product and utilization thereof
07/31/2003WO2003062415A2 Transgenic animal comprising intracellular immunoglobins for xenotransplantation
07/31/2003WO2003062414A2 Methods of obtaining isoform specific expression in mammalian cells
07/31/2003WO2003062410A2 Torero protein
07/31/2003WO2003062408A1 Virus-like particles
07/31/2003WO2003062406A1 Method for the production of resveratrol in cell cultures
07/31/2003WO2003062405A2 Method for inducing differentiation of embryonic stem cells
07/31/2003WO2003062400A2 Fiber shaft modifications for efficient targeting
07/31/2003WO2003062397A2 Methods of increasing transformation frequency of maize
07/31/2003WO2003062395A2 Predictor sets for tyrosine kinase pathways
07/31/2003WO2003062394A2 Methods and compositions for rna interference
07/31/2003WO2003062393A2 G protein-coupled receptor variants
07/31/2003WO2003062390A2 Compositions and methods for the modulation of sphingolipid metabolism and/or signaling
07/31/2003WO2003062386A2 Syndecans and angiogenesis
07/31/2003WO2003062385A2 Secretory molecules
07/31/2003WO2003062384A2 Stem cell maturation for all tissue types
07/31/2003WO2003062383A2 In vivo gene transfer
07/31/2003WO2003062382A2 Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in domesticated plants and animals
07/31/2003WO2003062381A2 Multiply-substituted protease variants
07/31/2003WO2003062380A2 Multiply-substituted protease variants
07/31/2003WO2003062379A2 Molecules for disease detection and treatment
07/31/2003WO2003062378A2 Methods of random mutagenesis and methods of modifying nucleic acids using translesion dna polymerases
07/31/2003WO2003062376A2 Molecules for diagnostics and therapeutics
07/31/2003WO2003062370A2 Multimeric proteins and methods of making and using same
07/31/2003WO2003062369A2 Expansion of renewable stem cell populations
07/31/2003WO2003062278A1 MONOCLONAL ANTIBODIES AGAINST EXTRACELLULAR LOOPS OF C5aR
07/31/2003WO2003062277A1 Corticotropin releasing factor receptor 2 agonists
07/31/2003WO2003062276A2 Multimers of receptor-binding ligands
07/31/2003WO2003062275A1 Glycoisoforms of adiponectin and uses thereof
07/31/2003WO2003062274A1 Novel proteins and dnas thereof
07/31/2003WO2003062273A2 Modulator of the notch signalling pathway and use thereof in medical treatment
07/31/2003WO2003062271A1 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof
07/31/2003WO2003062270A2 Fluorescent protein from aequorea coerulscens and uses therof
07/31/2003WO2003062269A2 Corticotropin releasing factor receptor 2 agonists
07/31/2003WO2003062268A2 Corticotropin releasing factor receptor 2 agonists
07/31/2003WO2003062264A2 Functional ligand display
07/31/2003WO2003062262A2 Modulation of heat-shock-protein-based immunotherapies
07/31/2003WO2003062258A1 Rnase l activator-antisense complexes
07/31/2003WO2003062197A2 Nek2 inhibitors
07/31/2003WO2003062173A2 Alanine 2,3- aminomutase
07/31/2003WO2003061710A1 AGENT CONTROLLING THE APOPTOSIS INDUCTION BY p73
07/31/2003WO2003061697A1 Preventives/remedies for cancer
07/31/2003WO2003061681A2 Proteins involved in the regulation of energy homeostasis and organelle metabolism
07/31/2003WO2003061601A2 Aminophospholipid transporter atpase
07/31/2003WO2003061596A2 Methods and reagents for generating chimeric serum peptide carri ers
07/31/2003WO2003061595A2 Antibodies against and compositions containing new amphetamine derivatives
07/31/2003WO2003061591A2 Stem cell-derived endothelial cells modified to disrupt tumor angiogenesis
07/31/2003WO2003061582A2 Generation of recombinant adeno-associated viral vectors by a complete adenovirus-mediated approach
07/31/2003WO2003061580A2 Alteration of rab38 function to modulate mammalian pigmentation
07/31/2003WO2003061573A2 Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058 or 6351 mo
07/31/2003WO2003061570A2 Engineered binding proteins
07/31/2003WO2003061564A2 Gene expression profiles in liver disease
07/31/2003WO2003061560A2 Replication competent dual-ad vectors for vaccine and immunotherapy applications
07/31/2003WO2003061386A1 Wt1 antisense oligos for the inhibition of breast cancer
07/31/2003WO2003061365A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
07/31/2003WO2003061363A2 Mutations caused by activation-induced cytidine deaminase
07/31/2003WO2003049538A3 Methods for the cost-effective saccharification of lignocellulosic biomass
07/31/2003WO2003046160A3 Methods of increasing protein expression levels
07/31/2003WO2003040339A3 Antisense modulation of purinoreceptor p2x¿3?
07/31/2003WO2003037253A3 Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616
07/31/2003WO2003035679A3 Molecules
07/31/2003WO2003030720A3 Materials and methods for preventing or reducing scar formation
07/31/2003WO2003029484A3 Antimicrobial methods and materials
07/31/2003WO2003028636A3 Antisense modulation of il-1 receptor-associated kinase-4 expression
07/31/2003WO2003027246A3 Antagonists
07/31/2003WO2003025140A3 Transductin-1 and transductin-2 and applications to hereditary deafness
07/31/2003WO2003024388A3 Methods and compositions for treating and preventing skin disorders using binding agents specific for psma
07/31/2003WO2003020702A9 Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain
07/31/2003WO2003016333A3 Virus coat protein/receptor chimeras and methods of use
07/31/2003WO2003014702A3 Uses of mammalian cytokine; related reagents
07/31/2003WO2003010243A3 Multipotent stem cells from peripheral tissues and uses thereof
07/31/2003WO2003010139A3 Antisense modulation of hormone-sensitive lipase expression
07/31/2003WO2003008642A3 Amplification of nucleic acid fragments using nicking agents
07/31/2003WO2003008630A3 Methods of profiling gene expression, protein or metabolite levels
07/31/2003WO2003008603A3 Process for the preparation of l-amino acids using strains of the enterobacteri acea family which contain an attenuated aspa gene
07/31/2003WO2003008602A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an attenuated ugpb gene
07/31/2003WO2003008578A3 Reagents and methods for identifying gene targets for treating cancer
07/31/2003WO2003006607A3 Inhibition of apoptosis process and improvement of cell performance
07/31/2003WO2003006499A3 Survivin interacting protein tpr1
07/31/2003WO2003006495A3 Human papillomavirus e2 transactivation domain/inhibitor co-crystal and x-ray coordinates defining the inhibitor-binding pocket
07/31/2003WO2003004670A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family with enhanced pts-g expression
07/31/2003WO2003004664A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family with enhanced fba expression
07/31/2003WO2003004607A3 Aggrecanase molecules
07/31/2003WO2003002736A3 A walk-through technique for in vitro recombination of polynucleotide sequences
07/31/2003WO2003001863A3 Novel endothelially expressed dnas and proteins, and their use
07/31/2003WO2003000024A3 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection
07/31/2003WO2002103320A3 Diagnosis and prognosis of breast cancer patients
1 ... 2460 2461 2462 2463 2464 2465 2466 2467 2468 2469 2470 2471 2472 2473 2474 2475 2476 2477 2478 2479 2480 ... 4023